Fingerprint
Dive into the research topics of 'A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically